Question Relevant to All Oncologists Answered at ASH 2017 Question Relevant to All Oncologists Answered at ASH 2017

Cancer patients are at higher risk for venous thromboembolism. To date, the standard treatment has been subcutaneous low-molecular-weight heparin products, but now there are data on newer oral agents.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news